Observatory · observe first

Follow the allocation change

Matched S&P 500 members → sector → industry → sub-industry → company. Each step uses the same percentage points.

Historical time machine

Historical observation

20182026

Universe›Health Care›Pharmaceuticals›Pharmaceuticals

1 · Sector

Weight and 12M allocation change

Materials27.4%+25.10 pp Energy2.1%-0.32 pp Communication Services2.0%-0.81 pp Utilities2.0%-0.92 pp Real Estate1.6%-0.95 pp Industrials7.6%-2.27 pp Consumer Discretionary8.9%-2.59 pp Consumer Staples4.7%-2.85 pp Financials7.8%-4.44 pp Information Technology28.4%-4.69 pp Health Care7.4%-5.25 pp

2 · Industry

Inside Health Care

Pharmaceuticals2.77%-1.46 pp Health Care Equipment1.24%-1.46 pp Biotechnology1.31%-0.76 pp Managed Health Care0.64%-0.64 pp Life Sciences Tools & Services0.59%-0.41 pp Health Care Services0.32%-0.23 pp Health Care Distributors0.29%-0.16 pp Health Care Facilities0.13%-0.08 pp Health Care Supplies0.06%-0.04 pp Health Care Technology0.02%-0.01 pp

3 · Sub-industry

Inside Pharmaceuticals

Pharmaceuticals2.77%-1.462 pp

Concentrated

Most of this industry's losses came from a few companies.

View all contributions →

Pharmaceuticals · weight

2.77%

Industry change · 12M

-1.46 pp

Pharmaceuticals · contribution

-1.462 pp

Company participation

of industry constituents above their 6M weight average

4 · Companies driving this sub-industry

Apr 2026 · sorted by absolute contribution to 12-month change

Company	Country	Market cap	Universe weight	3M contribution	12M contribution	12M price return	Above 6M weight average
Lilly (Eli) → LLY	United States	$880.2bn	1.194%	-0.682 pp	-0.853 pp	+4.7%	No
Johnson & Johnson → JNJ	United States	$553.3bn	0.751%	-0.297 pp	-0.152 pp	+51.1%	No
Merck & Co. → MRK	United States	$269.9bn	0.366%	-0.157 pp	-0.151 pp	+32.8%	No
Pfizer → PFE	United States	$151.8bn	0.206%	-0.082 pp	-0.126 pp	+17.3%	No
Zoetis → ZTS	United States	$48.5bn	0.066%	-0.039 pp	-0.102 pp	-25.3%	No
Bristol Myers Squibb → BMY	United States	$123.7bn	0.168%	-0.047 pp	-0.077 pp	+26.7%	No
Viatris → VTRS	United States	$17.2bn	0.023%	-0.006 pp	-0.001 pp	+85.7%	No

Company contributions use weights among matched S&P 500 members and add through each level without rescaling. Companies without matched shares and prices are omitted. These observations do not establish official index weights or actual fund flows.